Tango Therapeutics, Inc.
TNGX
$17.94
$0.643.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.03% | 18.54% | -24.96% | -18.46% | -28.07% |
| Total Depreciation and Amortization | -8.72% | -2.96% | 0.08% | 1.50% | 3.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.50% | 21.31% | 22.93% | 37.39% | 45.23% |
| Change in Net Operating Assets | -111.68% | -202.76% | -15.24% | -5.50% | 16.38% |
| Cash from Operations | -5.62% | -19.21% | -23.48% | -11.91% | -11.46% |
| Capital Expenditure | -38.99% | -10.98% | -20.74% | 44.60% | 50.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -145.83% | 115.00% | 746.52% | 56,723.79% | 102.27% |
| Cash from Investing | -147.45% | 116.31% | 719.28% | 9,732.98% | 107.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 366.88% | -91.54% | -96.87% | -96.27% | -42.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 366.81% | -91.50% | -96.86% | -96.26% | -42.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,767.58% | 183.16% | 19.87% | -189.39% | -60.87% |